CRANBURY, N.J., Jan. 5, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Chairman and Chief Executive Officer John F. Crowley will be presenting a business update and a review of the Company's expected key milestones for 2011 at the upcoming 29th Annual J.P. Morgan Healthcare Conference. Mr. Crowley's presentation is scheduled to begin on Tuesday, January 11 at 3:00 p.m. PST.
Individuals can listen to a live webcast of the presentation by logging on to the Investors section of the Amicus Therapeutics web site, http://www.amicustherapeutics.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's web site for 30 days.
About Amicus Therapeutics
Amicus Therapeutics is developing orally-administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of rare diseases including lysosomal storage disorders and diseases of neurodegeneration. Amicus' lead program is in Phase 3 for the treatment of Fabry disease.
FOLD-G
SOURCE Amicus Therapeutics